My wife is on Ozempic, and has very little issues with it. And despite all her other health issues, her T2 is in control since taking the drug.The drug is Tirzepatide made by Eli Lilley, It is currently licenced for T2D treatment. but today on the news it has been applied for general release as a weight loss drug and OTC use. So like Ozempic, it has been half inched by the drug company to serve its real large vista wonderdrug role. It is a once a week injection, and is claimed to lose 34lbs of weight in 16 months of trial.
Tirzepatide Once Weekly for the Treatment of Obesity | NEJM
Original Article from The New England Journal of Medicine — Tirzepatide Once Weekly for the Treatment of Obesitywww.nejm.org
The CEO of the company was interviewed by CNN and was asked if it suffers the same nasty events that the other drugs like Ozempic suffer such as thyroid cancer pancreatitis etc, and she answered that it has only had the standard safety tests and it was not known if there are any longer term effects. It has also not had any independant testing or review. It apparently does not have the same gastric distress that the others have, so loses one very important (IMO) treatment effect which is the kickback nausea from overeating so it loses the portiom control aspect of the treatment. It also, the CEO admits, needs to be taken for life because the weight loss is only temporary, and suffers an accelerated weight gain on completion of a course. Caveat Emptor, my friends,
So long as a drug is properly monitored and under medical control, then it is suitable for its primary function. For these new drugs, they were developed to treat Type 2 Diabetes, and seem to do that job as intended. What is becoming a problem is this off label use, and OTC use that siphons off stock for general sale, and deprives T2D patients of their medicine.Did you see my post on Gabepentin?
I can't believe the difference in my vision since stopping it!
My wife is on Ozempic, and has very little issues with it. And despite all her other health issues, her T2 is in control since taking the drug.
Reports are cominbg in that it has triggered medullary thyroid cancer in some patients.
Tirzepatide
This information from Lexicomp® explains what you need to know about this medication, including what it’s used for, how to take it, its side effects, and when to call your healthcare provider.www.mskcc.org
We have had at least two diagnoses by forum members after starting this class of medication. at least one incidence was reported to the Australian Authority by the equivalent of the yellow card. the other may have been reported via the UK yellow card system by the HCP but this has not been confirmed. It may be coincidence, or a latent condition flaring up, but we have seen n=1 evidence.The actual quote is this: ‘This drug has been shown to cause thyroid cancer in some animals. It is not known if this happens in humans.’
Nothing about patients. Please don’t misinform.
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?
We use cookies and similar technologies for the following purposes:
Do you accept cookies and these technologies?